BILLERICA, Mass., Jan. 30, 2014 /PRNewswire/ -- Axsun Technologies Inc., a wholly-owned subsidiary of Volcano Corporation (NASDAQ: VOLC) and a leading developer and manufacturer of advanced photonic components and subsystems, has announced the Qualification of their new Lead-Free Tunable Laser packaging platform. Axsun's new Lead-Free platform provides the same performance and reliability as previous generations and meets the requirements of the Reduction of Hazardous Substances (ROHS) Directive 2011/65/EU (also known as ROHS2). This new directive eliminates exemptions for several product categories, including Medical Devices that were present in the 2002 Directive. Axsun will begin sampling new Lead-Free Engines in May 2014.
"Axsun's Swept Laser OCT Engines are ideally suited for the real-time OCT imaging in Ophthalmic, and other imaging applications," said Peter Whitney, Chief Scientist at Axsun. "With this new platform, our Swept Laser products will also continue to meet the Environmental Responsibility needs of our OCT customers."
Axsun will demonstrate its new Swept Laser Engines and Data Acquisition products at booth 8315/315 at The SPIE BIOS/Photonics West Exhibition at the Moscone Center, San Francisco February 1-6th, 2014.
About Axsun Technologies
Axsun Technologies, Inc., a Volcano subsidiary, established in 1998, develops and manufactures MEMS-based optical engines for optical telecommunications, industrial spectroscopy, and medical imaging, applications. Through its expertise in micro-optics, packaging and precision engineering, Axsun has pioneered an entirely new class of high-performance, miniaturized instruments and devices enabling a dramatic shift from lab based measurements to on-line, at-line and in-vivo measurements, without compromising performance. Axsun was acquired by Volcano Corporation in December 2008. For more information, visit Axsun's website at www.axsun.com.
About Volcano Corporation
Volcano Corporation is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Its products empower physicians around the world with a new generation of analytical tools that deliver more meaningful information - using sound and light as the guiding elements. Founded in cardiovascular care and expanding into other specialties, Volcano is changing the assumption about what is possible in improving patient outcomes by combining imaging and therapy together. For more information, visit the company's website at www.volcanocorp.com.
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered "forward-looking statements" including statements regarding the potential performance and benefits of the Axsun products described above. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties which may cause results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ include the pace and extent of market adoption of Axsun's products and technologies, outcome of ongoing litigation, market conditions, and other risks inherent to photonic development and commercialization. These and additional risks and uncertainties are more fully described in Volcano's filings made with the Securities and Exchange Commission, including our recent quarterly report on Form 10-Q. Undue reliance should not be placed on forward-looking statements which speak only as of the date they are made. Volcano undertakes no obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they are made, or to reflect the occurrence of unanticipated events.
SOURCE Axsun Technologies, Inc.